6 results
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
pharmacotherapy trials in BPD ... following outcomes: BPD ... symptoms, mental ... the UK national BPD ... #BPD #Borderline
Acute Kidney Injury (AKI) - Management Principles
Prerenal - Correct hemodynamic derangements:
 • If low preload →
Acute Kidney Injury ... midodrine + albumin Intrarenal ... → No specific treatment ... → Stop meds • BPH ... Kidney #Injury #treatment
Management of Serotonin Syndrome
Identify and stop all serotoninergic medications
 • Avoid inadvertent Rx of serotoninergic meds
serotoninergic medications ... normalize vital signs ... mildly elevated HR/BP ... then 2 mg q2h if symptoms ... Syndrome #Management #treatment
Therapy for Benign Prostatic Hyperplasia (BPH) 
5 Alpha-Reductase inhibitors
 • Flnasterlde and dutasterlde act by reducing
Prostatic Hyperplasia (BPH ... Treatment for 6 ... of BPH, such as ... #Hyperplasia #BPH ... #Pharmacology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
hours or longer/BP ... Neurological symptoms ... Electrolyte abnormality, Medication ... patients - 10-25% BP ... overaggressive BP
Lithium Therapy for Bipolar Disorder 
Toxicity Levels: 
 - Mild (1-1.5 mEq/L) 
 - Moderate (1.6-2.5
gain Toxicity Symptoms ... Lithium is a medication ... maintenance agent for treatment ... Bipolar #Disorder #BPD ... #Toxicity #Pharmacology